Koninklijke Philips N.V. (PHG)
| Market Cap | 26.70B |
| Revenue (ttm) | 20.86B |
| Net Income (ttm) | 193.59M |
| Shares Out | 950.98M |
| EPS (ttm) | 0.21 |
| PE Ratio | 137.92 |
| Forward PE | 15.31 |
| Dividend | $0.82 (2.93%) |
| Ex-Dividend Date | May 13, 2025 |
| Volume | 450,684 |
| Open | 28.08 |
| Previous Close | 28.23 |
| Day's Range | 28.01 - 28.32 |
| 52-Week Range | 21.48 - 29.54 |
| Beta | 0.91 |
| Analysts | Strong Buy |
| Price Target | n/a |
| Earnings Date | Nov 4, 2025 |
About PHG
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, ... [Read more]
Financial Performance
In 2024, Koninklijke Philips's revenue was 18.02 billion, a decrease of -0.81% compared to the previous year's 18.17 billion. Losses were -702.00 million, 50.6% more than in 2023.
Financial numbers in EUR Financial StatementsNews
Philips reiterates timing of 2026 outlook
December 4, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 1...
XENOVIEW® 3T coil passes Philips compatibility testing
Polarean's FDA cleared coil achieves important milestone, expanding clinical reach Polarean's FDA cleared coil achieves important milestone, expanding clinical reach
Philips expands commercial availability of world's first real-time AI-enabled light-based 3D navigation solution for image-guided therapy
December 1, 2025 Commercial availability expanded across Europe and the United States Real-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex en...
Philips launches Verida, world's first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1] CE-marked...
Philips unveils BlueSeal Horizon, industry's first helium-free 3.0T MRI platform
November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – ...
Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere
November 24, 2025 New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX:...
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips' leadership in precision diagnostics in neurology
November 19, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership with Cortechs.ai, a pioneer in quanti...
Philips brings AI into the procedure room to assist doctors during heart valve repair
November 17, 2025 Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence** Amsterdam, the Neth...
Philips lays off 33 employees at Seattle-area healthcare device manufacturing facility
Philips Ultrasound is laying off 33 employees from its Bothell, Wash.
Koninklijke Philips N.V. (PHG) Q3 2025 Earnings Call Transcript
Koninklijke Philips N.V. ( PHG) Q3 2025 Earnings Call November 4, 2025 4:00 AM EST Company Participants Durga Doraisamy - Head of Investor Relations Roy Jakobs - President, CEO & Chairman of the Boar...
Philips Expects Full-Year Profitability to Land at Upper-End of Range
Sales growth and productivity measures at the health-technology company lifted earnings in the third quarter.
Philips reports 3% rise in quarterly sales
Dutch medical technology company Philips reported third-quarter revenue in line with analysts' expectations un Tuesday, citing a strong performance in North America.
Philips continues momentum; delivers strong order intake, step-up in sales growth and margin expansion
November 4, 2025 Q3 2025 Group Highlights Comparable order intake growth 8% Group sales amounted to EUR 4.3 billion, reflecting 3% increase in comparable sales Income from operations was EUR 330 milli...
Philips Joins the Forever Promise Project to Honor American Veterans
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its support of the Forever Promise Project, an initiative of the Monument...
Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA
October 30, 2025 10-year collaboration aims to connect scalable monitoring technology that streamlines workflows, supporting patient safety and the patient and clinician experience Amsterdam, the Neth...
Longleaf Partners Global Fund Q3 2025 Notable Contributors & Detractors
Our investments are grounded in real assets and brands producing growing free cash flow per share. We believe the Fund's FCF today can go to a mid-teens FCF multiple on growing FCF per share. We belie...
Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant di...
Philips Ultrasound Devices Deemed Adulterated Over Manufacturing And Oversight Lapses
The U.S. Food and Drug Administration (FDA) found that devices made at Koninklijke Philips N.V.'s (NYSE:PHG) Bothell, Reedsville, and Nederland facilities were adulterated due to manufacturing, storag...
US FDA sends warning letter to Philips over three device production facilities
The U.S. Food and Drug Administration has issued a warning letter to Philips after inspections at three of its medical device facilities found they had failed to meet required manufacturing standards,...
Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI
October 27, 2025 New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchroni...
Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide
October 8, 2025 Global adoption milestone underscores innovation in mobile C-arm surgical and interventional imaging, with more than 15 million patients treated in 170+ countries every year Amsterdam,...
UAE Residents embrace proactive, tech-driven, and sustainable healthcare, according to the second edition of Philips Health Trends Research*
DUBAI, UAE, Oct. 7, 2025 /PRNewswire/ -- Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, has released the second edition of The Philips Health Trends Research UAE. Condu...
Official Philips Home Access Online Store Has Been Launched — Up to 60 % OFF, Free Shipping and Exclusive Giveaways
ONTARIO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- The official Philips Home Access online store has been launched at homeaccess.philips , offering U.S. consumers direct access to a full range of key...
Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025
September 26, 2025 New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term value Philips d ebuts helium-free [2] BlueSeal R...
Philips joins Optum Healthcare's network as a preferred provider in the USA
September 25, 2025 Philips' ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring Amsterdam, the Netherlands ...